Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

5.9K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
5.9K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

602
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
602
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

571
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
571
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.5K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.5K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

1.5K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.5K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

1.3K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of resting heart rate on coronary collateral formation in patients with chronic total occlusion: resting heart rate and collaterals.

Cardiovascular journal of Africa·2026
Same author

Contact Lenses for Visual Habilitation in Infantile Aphakia: Long-Term Visual Outcomes and Factors Affecting Treatment Success.

Eye & contact lens·2025
Same author

Shockwave therapy technique: Concerns around a recent publication.

Clinical rehabilitation·2025
Same author

Applying the WHO ICF framework to long COVID patients with persistent respiratory symptoms.

Turkish journal of physical medicine and rehabilitation·2024
Same author

Obstructive Sleep Apnea and Cardiovascular Disease: Where Do We Stand?

Anatolian journal of cardiology·2023
Same author

Is isoenergetic high-intensity interval exercise superior to moderate-intensity continuous exercise for cardiometabolic risk factors in individuals with type 2 diabetes mellitus? A single-blinded randomized controlled study.

European journal of sport science·2023

Related Experiment Video

Updated: Apr 14, 2026

Supramaximal Intensity Hypoxic Exercise and Vascular Function Assessment in Mice
10:00

Supramaximal Intensity Hypoxic Exercise and Vascular Function Assessment in Mice

Published on: March 15, 2019

9.0K

Effect of 10-Week Supervised Moderate-Intensity Intermittent vs. Continuous Aerobic Exercise Programs on Vascular

Sibel Aksoy1, Gulin Findikoglu, Fusun Ardic

  • 1From the Departments of Physical Medicine and Rehabilitation (SA, GF, FA), Biochemistry (SR), and Cardiology (DD), Faculty of Medicine, University of Pamukkale, Denizli, Turkey.

American Journal of Physical Medicine & Rehabilitation
|April 19, 2015
PubMed
Summary

Both continuous and intermittent aerobic exercise programs effectively reduced adhesion molecules in chronic heart failure patients. Exercise improved endothelial function and disease markers, enhancing quality of life.

More Related Videos

Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
07:40

Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training

Published on: October 10, 2019

7.9K
Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
04:20

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure

Published on: October 1, 2019

6.4K

Related Experiment Videos

Last Updated: Apr 14, 2026

Supramaximal Intensity Hypoxic Exercise and Vascular Function Assessment in Mice
10:00

Supramaximal Intensity Hypoxic Exercise and Vascular Function Assessment in Mice

Published on: March 15, 2019

9.0K
Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
07:40

Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training

Published on: October 10, 2019

7.9K
Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
04:20

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure

Published on: October 1, 2019

6.4K

Area of Science:

  • Cardiology
  • Exercise Physiology
  • Vascular Biology

Background:

  • Endothelial dysfunction, marked by abnormal cellular adhesion molecules, is central to chronic heart failure (CHF).
  • Exercise interventions are explored for their potential to mitigate endothelial damage and improve CHF outcomes.

Purpose of the Study:

  • To compare the effects of 10-week moderate-intensity continuous aerobic exercise (CAE) and intermittent aerobic exercise (IAE) programs.
  • To assess the impact on endothelial damage markers, disease severity, functional status, and quality of life in CHF patients.

Main Methods:

  • Fifty-seven CHF patients (NYHA class II-III) were randomized into control, CAE, or IAE groups.
  • Interventions lasted 10 weeks, with exercise performed three times weekly.
  • Endothelial markers, cardiac function (LVEF), cardiorespiratory fitness, and quality of life were assessed.

Main Results:

  • Both CAE and IAE significantly reduced serum markers of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1.
  • The CAE group showed improvements in blood pressure, 6-minute walking distance, and mental health/vitality.
  • The IAE group demonstrated improvements in left ventricular ejection fraction and 6-minute walking distance.

Conclusions:

  • Moderate-intensity CAE and IAE programs are effective in reducing adhesion molecules in CHF patients.
  • Both exercise types help prevent declines in cardiorespiratory fitness (VO2).
  • Exercise interventions offer benefits for endothelial function and overall well-being in chronic heart failure.